Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis

NCT04333160 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

746

Enrollment

INDUSTRY

Sponsor class

Conditions

Symptomatic Osteoarthritis of the Knee

Interventions

DRUG: JTA-004
DEVICE: Hylan G-F 20
OTHER: placebo

Sponsor

Bone Therapeutics S.A

Collaborators

[object Object]